263 related articles for article (PubMed ID: 21787393)
1. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
2. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
Wajih N; Sane DC
Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and angiogenesis.
Rundhaug JE
J Cell Mol Med; 2005; 9(2):267-85. PubMed ID: 15963249
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
Patterson BC; Sang QA
J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
[TBL] [Abstract][Full Text] [Related]
6. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
Falcone DJ; Khan KM; Layne T; Fernandes L
J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
[TBL] [Abstract][Full Text] [Related]
7. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
[TBL] [Abstract][Full Text] [Related]
8. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin binds ATP synthase on the surface of human endothelial cells.
Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
[TBL] [Abstract][Full Text] [Related]
10. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
11. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
Cornelius LA; Nehring LC; Harding E; Bolanowski M; Welgus HG; Kobayashi DK; Pierce RA; Shapiro SD
J Immunol; 1998 Dec; 161(12):6845-52. PubMed ID: 9862716
[TBL] [Abstract][Full Text] [Related]
13. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.
Pozzi A; Moberg PE; Miles LA; Wagner S; Soloway P; Gardner HA
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2202-7. PubMed ID: 10681423
[TBL] [Abstract][Full Text] [Related]
14. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide.
Matsunaga T; Weihrauch DW; Moniz MC; Tessmer J; Warltier DC; Chilian WM
Circulation; 2002 May; 105(18):2185-91. PubMed ID: 11994253
[TBL] [Abstract][Full Text] [Related]
15. Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems.
Narasaki R; Kuribayashi H; Shimizu K; Imamura D; Sato T; Hasumi K
J Biol Chem; 2005 Apr; 280(14):14278-87. PubMed ID: 15677446
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin-like molecules are generated by snake venom metalloproteinases.
Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
[TBL] [Abstract][Full Text] [Related]
17. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
Tarui T; Miles LA; Takada Y
J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
[TBL] [Abstract][Full Text] [Related]
18. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
20. The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions.
Drinane M; Walsh J; Mollmark J; Simons M; Mulligan-Kehoe MJ
J Biol Chem; 2006 Nov; 281(44):33336-44. PubMed ID: 16950776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
